These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38604536)

  • 1. [Laparoscopic ultrasound-guided radiofrequency ablation of uterine fibroid: A retrospective study].
    Bertogli H; Lucot JP; Lafourcade J; Warembourg S; Detchev R; Nguyen Ba E; Dubernard G; Philip CA
    Gynecol Obstet Fertil Senol; 2024 Sep; 52(9):495-504. PubMed ID: 38604536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Prospective Intervention Trial on Tailored Radiofrequency Ablation of Uterine Myomas.
    Fasciani A; Turtulici G; Siri G; Ferrero S; Sirito R
    Medicina (Kaunas); 2020 Mar; 56(3):. PubMed ID: 32178351
    [No Abstract]   [Full Text] [Related]  

  • 3. Ultrasound-guided transvaginal radiofrequency myolysis for symptomatic uterine myomas.
    Jiang X; Thapa A; Lu J; Bhujohory VS; Liu Y; Qiao S
    Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():38-43. PubMed ID: 24766899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine Myoma Position-based Radiofrequency Ablation (UMP-b RFA): 36 months follow-up clinical outcomes.
    Fasciani A; Turtulici G; Pedullà A; Sirito R
    Eur J Obstet Gynecol Reprod Biol; 2023 Feb; 281():23-28. PubMed ID: 36527825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laparoscopic ultrasound-guided radiofrequency volumetric thermal ablation of symptomatic uterine leiomyomas: feasibility study using the Halt 2000 Ablation System.
    Garza Leal JG; Hernandez Leon I; Castillo Saenz L; Lee BB
    J Minim Invasive Gynecol; 2011; 18(3):364-71. PubMed ID: 21545960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of Life, Adverse Events, and Reintervention Outcomes after Laparoscopic Radiofrequency Ablation for Symptomatic Uterine Fibroids: A Meta-Analysis.
    Lin L; Ma H; Wang J; Guan H; Yang M; Tong X; Zou Y
    J Minim Invasive Gynecol; 2019; 26(3):409-416. PubMed ID: 30253997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The FAST-EU trial: 12-month clinical outcomes of women after intrauterine sonography-guided transcervical radiofrequency ablation of uterine fibroids.
    Brölmann H; Bongers M; Garza-Leal JG; Gupta J; Veersema S; Quartero R; Toub D
    Gynecol Surg; 2016; 13():27-35. PubMed ID: 26918001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot Study of the Mirabilis System Prototype for Rapid Noninvasive Uterine Myoma Treatment Using an Ultrasound-Guided Volumetric Shell Ablation Technique.
    Parsons JE; Lau MPH; Martin PJ; Islas Lagos JJ; Aguilar Aguirre JM; Garza Leal JG
    J Minim Invasive Gynecol; 2017; 24(4):579-591. PubMed ID: 28109895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound-Guided High Intensity Focused Ultrasound Ablation for Symptomatic Uterine Fibroids: Preliminary Clinical Experience.
    Lyon PC; Rai V; Price N; Shah A; Wu F; Cranston D
    Ultraschall Med; 2020 Oct; 41(5):550-556. PubMed ID: 31238385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcervical, intrauterine ultrasound-guided radiofrequency ablation of uterine fibroids with the VizAblate® System: three- and six-month endpoint results from the FAST-EU study.
    Bongers M; Brölmann H; Gupta J; Garza-Leal JG; Toub D
    Gynecol Surg; 2015; 12(1):61-70. PubMed ID: 25774122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What predicts durable symptom relief of uterine fibroids treated with MRI-guided focused ultrasound? A multicenter trial in 8 academic centers.
    Bitton RR; Fast A; Vu KN; Lum DA; Chen B; Hesley GK; Raman SS; Matsumoto AH; Price TM; Tempany C; Dhawan N; Dolen E; Kohi M; Fennessey FM; Ghanouni P
    Eur Radiol; 2023 Nov; 33(11):7360-7370. PubMed ID: 37553488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of fibroid-associated symptoms and quality of life after US-guided high-intensity focused ultrasound (HIFU) of uterine fibroids.
    Tonguc T; Recker F; Ganslmeier J; Strunk HM; Pieper CC; Ramig O; Welz S; Egger EK; Mutschler N; Warwas L; Essler M; Mustea A; Conrad R; Marinova M
    Sci Rep; 2022 Dec; 12(1):21155. PubMed ID: 36476975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiofrequency Thermal Ablation for Uterine Myomas: Long-term Clinical Outcomes and Reinterventions.
    Iversen H; Dueholm M
    J Minim Invasive Gynecol; 2017; 24(6):1020-1028. PubMed ID: 28662989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transvaginal ultrasound-guided radiofrequency myolysis for uterine myomas.
    Kim CH; Kim SR; Lee HA; Kim SH; Chae HD; Kang BM
    Hum Reprod; 2011 Mar; 26(3):559-63. PubMed ID: 21216788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasound-guided high-intensity focused ultrasound treatment for uterine fibroid & adenomyosis: A single center experience from the Republic of Korea.
    Lee JS; Hong GY; Park BJ; Kim TE
    Ultrason Sonochem; 2015 Nov; 27():682-687. PubMed ID: 26072367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Laparoscopic ultrasound-guided radiofrequency ablation of uterine fibroids].
    Mounien D; Martel C; Faller E
    Gynecol Obstet Fertil Senol; 2023; 51(7-8):384-386. PubMed ID: 37276921
    [No Abstract]   [Full Text] [Related]  

  • 17. Ultrasound-guided radiofrequency ablation of symptomatic uterine fibroids: short-term evaluation of effect of treatment on quality of life and symptom severity.
    Iversen H; Lenz S; Dueholm M
    Ultrasound Obstet Gynecol; 2012 Oct; 40(4):445-51. PubMed ID: 22378629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of ultrasound-guided percutaneous microwave ablation for symptomatic uterine fibroids: a multicentre study in China.
    Liu H; Zhang J; Han ZY; Zhang BS; Zhang W; Qi CS; Yu SY; Li HZ; Su HH; Duan XM; Li QY; Li XM; Xu RF
    Int J Hyperthermia; 2016 Dec; 32(8):876-880. PubMed ID: 27405972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Performance of Radiofrequency Ablation for Treatment of Uterine Fibroids: Systematic Review and Meta-Analysis of Prospective Studies.
    Bradley LD; Pasic RP; Miller LE
    J Laparoendosc Adv Surg Tech A; 2019 Dec; 29(12):1507-1517. PubMed ID: 31702440
    [No Abstract]   [Full Text] [Related]  

  • 20. Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
    Murji A; Whitaker L; Chow TL; Sobel ML
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010770. PubMed ID: 28444736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.